An Introduction To Organ-On-A-Chip Technology

Bringing a new drug to the market is a massive undertaking, but conventional preclinical models often fail to predict human response. This failure is a major reason why 90% of drugs that pass the preclinical stage ultimately fail during human trials. However, Organ-on-a-Chip technology offers a paradigm shift in drug development. By replicating the complex microenvironment of human organs, researchers can now obtain more accurate data on drug responses in a shorter time frame.

In this guide, we will explore the world of Organ-on-a-Chip technology, its potential to reshape disease research and drug development, and how it can overcome the limitations of traditional models. Organ-Chips hold the promise of providing insights at every stage of the drug development pipeline, thus accelerating the discovery of life-saving treatments.